Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment

By sjmartinez • June 28, 2023

Gilham D, Wasiak S, Rakai BD, Fu L, Tsujikawa LM, Sarsons CD, Carestia A, Lebioda K, Johansson JO, Sweeney M, Kalantar-Zadeh K, Kulikowski E. Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 2023 Jun 8;11(6):1663. doi: 10.3390/biomedicines11061663. PMID: 37371758.

Tags: apabetalone, BET proteins, chronic kidney disease (CKD), epigenetics, fibrosis, gene expression, Harbor UCLA, Inflammation, Nephrology, Publications

Comparative assessment of CAC and SIS plaque burden categories via AI-guided quantitative CT analysis

Iskander B, Ichikawa K, Punnanithinont N, Kambalapalli S, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Comparative assessment of CAC and SIS plaque[...]

Reply: Keto CTA Study

Soto-Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, Feldman D, Budoff M. Reply: Keto CTA Study. JACC Adv. 2025 May 7;4(7):101862.[...]

Mild to moderate COPD, vitamin D deficiency, and longitudinal bone loss: The MESA study

Ghotbi E, Hathaway QA, Hadidchi R, Momtazmanesh S, Bancks MP, Bluemke DA, Barr RG, Post WS, Budoff M, Smith BM, Lima JAC, Demehri S. Mild[...]